je.st
news
Merck Demands $3 Billion In HCV Royalties From Gilead
2016-03-11 20:20:18| Biotech - Topix.net
Merck wants to Bogart a $3B royalty payment equal to 10% of the $31.7B Gilead has made from HCV sales. Gilead has had a target on its back from regulators, competitors and politicians ever since its blockbuster HCV regimen hit the market.
Tags: billion
demands
merck
royalties
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||